首页> 外文会议>Annual International Conference of the IEEE Engineering in Medicine and Biology Society >Optimizing Individualized Treatment Planning for Parkinson’s Disease Using Deep Reinforcement Learning
【24h】

Optimizing Individualized Treatment Planning for Parkinson’s Disease Using Deep Reinforcement Learning

机译:利用深度强化学习优化帕金森氏病的个性化治疗计划

获取原文

摘要

More than one million people currently live with Parkinson’s Disease (PD) in the U.S. alone. Medications, such as levodopa, can help manage PD symptoms. However, medication treatment planning is generally based on patient history and limited interaction between physicians and patients during office visits. This limits the extent of benefit that may be derived from the treatment as disease/patient characteristics are generally non-stationary. Wearable sensors that provide continuous monitoring of various symptoms, such as bradykinesia and dyskinesia, can enhance symptom management. However, using such data to overhaul the current static medication treatment planning approach and prescribe personalized medication timing and dosage that accounts for patient/care-giver/physician feedback/preferences remains an open question. We develop a model to prescribe timing and dosage of medications, given the motor fluctuation data collected using wearable sensors in real-time. We solve the resulting model using deep reinforcement learning (DRL). The prescribed policy determines the optimal treatment plan that minimizes patient’s symptoms. Our results show that the model-prescribed policy outperforms the static a priori treatment plan in improving patients’ symptoms, providing a proof-of-concept that DRL can augment medical decision making for treatment planning of chronic disease patients.
机译:仅在美国,目前有超过100万人患有帕金森氏病(PD)。左旋多巴等药物可帮助治疗PD症状。但是,药物治疗计划通常是基于患者的病史以及在办公室就诊期间医师与患者之间有限的互动。由于疾病/患者特征通常是不稳定的,因此这限制了可从治疗中受益的程度。可穿戴式传感器提供对各种症状(例如运动迟缓和运动障碍)的连续监测,可以增强症状管理。然而,使用这样的数据来检查当前的静态药物治疗计划方法并规定考虑患者/护理人员/医师反馈/偏好的个性化药物时机和剂量仍然是一个悬而未决的问题。考虑到使用可穿戴式传感器实时收集的电机波动数据,我们开发了一个模型来规定用药的时间和剂量。我们使用深度强化学习(DRL)解决生成的模型。规定的政策将确定最佳治疗计划,以最大程度地减少患者的症状。我们的结果表明,该模型规定的策略在改善患者症状方面优于静态的先验治疗计划,这提供了概念证明,即DRL可以增强针对慢性病患者的治疗计划的医疗决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号